Inhibition of prolactin release by a benzodioxinylimidazoline de

Details Inhibition of prolactin release by a benzodioxinylimidazoline de Inhibition of prolactin release by a benzodioxinylimidazoline de

1983-12-01

1987-01-06

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31415

Patent

active

046347143

ABSTRACT:
2-(2,3-Dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole, or a pharmaceutically acceptable salt thereof, is useful in the treatment of hyperprolactinemic states in warm-blooded animals.

REFERENCES:
patent: 4302469 (1981-11-01), Kluge et al.
patent: 4315021 (1982-02-01), Kluge et al.
patent: 4397860 (1983-08-01), Chapleo et al.
patent: 4402967 (1983-09-01), Waterbury
Physician's Desk Reference, "Parlodel.RTM." pp. 1748-1749 (1984).
Parkes, N. Eng. J. Med., 301, 873 (1979).
Caroon et al., J. Med. Chem., 25, 666 (1982).
Meltzer et al., J. Pharm. Exp. Ther., 224, 21 (1983).

Affiliated with

Also associated with

Rating

Inhibition of prolactin release by a benzodioxinylimidazoline de does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of prolactin release by a benzodioxinylimidazoline de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of prolactin release by a benzodioxinylimidazoline de will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-684324